Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 7 | |
Outperform | 15 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 21 analysts offering 12 month price targets for Legend Biotech Corp (ADR) have a median target of 86.00, with a high estimate of 95.00 and a low estimate of 60.00. The median estimate represents a 69.19% increase from the last price of 50.83.
High | 86.9% | 95.00 |
Med | 69.2% | 86.00 |
Low | 18.0% | 60.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 18, 2024.
Average growth rate | +15.91% |
Average growth rate | -38.80% |
More ▼
Revenue history & estimates in USD
Average growth rate | +32.61% |
Average growth rate | +64.22% |
More ▼